Sort
15,273 grants matching “antimicrobial resistance”
The oral mucosal proteome: perturbation in HIV infection and Candida co infection
$256,434Stephen J Challacombe · King'S College London · R01 · FY2008 · DE
Synthesis of Lactonamycin and Related Polyketides
$256,402Rice University · R01 · FY2004 · AI
Defense of oral epithelial cells from candida by hBDs
$256,365Aaron Weinberg · Case Western Reserve University · R01 · FY2007 · DE
Development of synergistic clofazimine-amikacin inhalable powders for the treatment of pulmonary Mycobacterium abscessus infections
$256,350Zachary N Warnken · Via Therapeutics, Llc · R43 · FY2021 · AI
Protective film-forming disinfectant based on chitosan/water/ethanol tertiary solutions
$256,321Alexey A Vertegel · Vrm Labs Inc · R41 · FY2021 · AI
Burkholderia pseudomallei antimicrobial resistance mechanisms
$256,314Herbert P. Schweizer · Colorado State University · U54 · FY2012 · AI
Collaborative Research: Smart Dental Implant System for Ambulatory Dental Care
$256,240Albert Kim · University Of South Florida · · FY2022 · ENG
Engineering the open porous nanofibrous microsphere integrated fibrillar hydrogel for the co-delivery of antibacterial and angiogenic agents aimed at the rapid diabetic wound repair
$256,185Johnson Vitharikunnil John · Terasaki Institute For Biomedical Innovation · R01 · FY2023 · DK
Synthesis of Lactonamycin and Related Polyketides
$256,167Rice University · R01 · FY2005 · AI
Modeling Membrane Binding and Permeabilization by Antimicrobial Peptides
$256,113Themis Lazaridis · City College Of New York · SC1 · FY2010 · AI
SBIR Phase I: Phage-amplified Identification and Antimicrobial Susceptibility Test
$256,000Christopher Cox · Cobio Diagnostics Inc. · · FY2021 · TIP
SBIR Phase I: Regenerable Antimicrobial Paints Based on Hydrogen Peroxide
$255,999William Toreki · Quick-Med Technologies, In · · FY2021 · TIP
SBIR Phase I: A Rapid, Sensitive Pathogen Typing and Antibiotic Sensitivity Test for Bloodstream Infections (COVID-19)
$255,834Rachel Kulberg · Kepley Biosystems Incorporated · · FY2021 · TIP
SURFACE PROTEIN ANCHORING IN GRAM POSITIVE BACTERIA
$255,738University Of California Los Angeles · R01 · FY2000 · AI
Antimicrobial Peptides in Resistance to Tuberculosis
$255,626National Jewish Health · R21 · FY2002 · AI
Pathogenesis of staphylococcal biofilm-related infection
$255,481Michael Otto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Nicotinamide-An Immune-Boosting Agent to Combat Antibiotic-Resistant Pathogens
$255,000George Y Liu · Cedars-Sinai Medical Center · R21 · FY2015 · AI
New understanding of LTA as a determinant of daptomycin susceptibility in VRE E. faecium
$255,000Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R21 · FY2019 · AI
Nonlinear Dynamics in Structured Biological and Epidemiological Models
$255,000Shigui Ruan · University Of Miami · · FY2014 · MPS
Development of Novel Therapeutics for Treatment of Mycobacterial Infections
$254,995Elton Jeffrey North · Creighton University · P20 · FY2021 · GM
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases
$254,626John McLeod Griffiss · Icon Government And Public Health Solutions, Inc. · N01 · FY2014 · AI
COBRE: UID: PROJ 2: EVOLUTION OF ANTIBIOTIC RESISTANCE PLASMIDS
$254,581Eva M. Top · University Of Idaho · P20 · FY2008 · RR
Mechanisms underlying poor skin host defense in diabetic conditions
$254,580C. Henrique Serezani · Vanderbilt University Medical Center · R21 · FY2020 · AI
BETA-DEFENSINS IN THE FEMALE GENITAL TRACT AND KIDNEYS
$254,536University Of California Los Angeles · R01 · FY2000 · AI
Identifying Mechanisms of Resistance to Pathogen-Specific Antibacterial Antisense Compounds and Strategies to Circumvent Them
$254,478David Elihu Greenberg · Ut Southwestern Medical Center · R21 · FY2025 · AI